应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARWR Arrowhead Research Corporation
交易中 07-22 15:01:10 EDT
28.66
+0.36
+1.25%
最高
28.82
最低
27.83
成交量
39.19万
今开
28.47
昨收
28.30
日振幅
3.48%
总市值
35.59亿
流通市值
31.72亿
总股本
1.24亿
成交额
1,113万
换手率
0.35%
流通股本
1.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.04%报28.05美元
自选股智能写手 · 07-17
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.04%报28.05美元
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.23%报30.37美元
自选股智能写手 · 07-16
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.23%报30.37美元
美国研究综述-星座品牌公司、边疆集团控股公司、精神航空公司
Reuters · 07-05
美国研究综述-星座品牌公司、边疆集团控股公司、精神航空公司
BUZZ--美国股票走势-Arrowhead Pharmaceuticals、Nvidia、Alimera Sciences
Reuters · 06-25
BUZZ--美国股票走势-Arrowhead Pharmaceuticals、Nvidia、Alimera Sciences
BUZZ--美国股票走势-布洛克、梅塔、Eos 能源
Reuters · 06-24
BUZZ--美国股票走势-布洛克、梅塔、Eos 能源
BUZZ-肥胖症治疗临床前数据良好,Arrowhead 公司业绩攀升
Reuters · 06-24
BUZZ-肥胖症治疗临床前数据良好,Arrowhead 公司业绩攀升
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.11%报25.90美元
自选股智能写手 · 06-12
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.11%报25.90美元
美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司
Reuters · 06-04
美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司
美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司
Reuters · 06-04
美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司
BUZZ-遗传性疾病治疗试验成功,艾睿达公司获益匪浅
Reuters · 06-03
BUZZ-遗传性疾病治疗试验成功,艾睿达公司获益匪浅
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.12%
自选股智能写手 · 05-28
Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.12%
Arrowhead Pharmaceuticals, Inc.2024财年第一财季实现净利润-1.25亿美元,同比减少356.78%
自选股智能写手 · 05-18
Arrowhead Pharmaceuticals, Inc.2024财年第一财季实现净利润-1.25亿美元,同比减少356.78%
Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.12%报23.19美元
自选股智能写手 · 05-14
Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.12%报23.19美元
大摩:维持Arrowhead Pharma(ARWR.US)评级,由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。
智通财经 · 05-14
大摩:维持Arrowhead Pharma(ARWR.US)评级,由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.40%报23.39美元
自选股智能写手 · 05-10
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.40%报23.39美元
美国研究综述-Cerence、Epam Systems、Progyny
Reuters · 05-10
美国研究综述-Cerence、Epam Systems、Progyny
Arrowhead Pharmaceuticals Inc 公布截至三月份的季度业绩 - 收益摘要
Reuters · 05-10
Arrowhead Pharmaceuticals Inc 公布截至三月份的季度业绩 - 收益摘要
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.03%
自选股智能写手 · 04-10
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.03%
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.21%报26.77美元
自选股智能写手 · 04-02
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.21%报26.77美元
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.04%
自选股智能写手 · 03-21
Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.04%
公司概况
公司名称:
Arrowhead Research Corporation
所属市场:
NASDAQ
上市日期:
--
主营业务:
Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立,后在特拉华州重新注册成立。该公司开发药物,通过沉默疾病的基因来治疗疑难杂症。使用广泛的RNA化学组合和高效的递送模式,该公司的疗法触发RNA干扰机制,以诱导目标基因的快速、深度和持久敲低。该公司已将资源集中于在跨越多个治疗领域的多个动物模型中独家利用其高水平药理活性的疗法。
发行价格:
--
{"stockData":{"symbol":"ARWR","market":"US","secType":"STK","nameCN":"Arrowhead Research Corporation","latestPrice":28.655,"timestamp":1721674869246,"preClose":28.3,"halted":0,"volume":391897,"delay":0,"floatShares":110692511,"shares":124200230,"eps":-4.233567,"marketStatus":"交易中","marketStatusCode":2,"change":0.355,"latestTime":"07-22 15:01:10 EDT","open":28.47,"high":28.815,"low":27.83,"amount":11133737.728729,"amplitude":0.034806,"askPrice":28.67,"askSize":108,"bidPrice":28.63,"bidSize":33,"shortable":3,"etf":0,"ttmEps":-4.233567,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":740203200000,"adjPreClose":28.3,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":28.5,"preClose":28.3,"latestTime":"09:29 EDT","volume":213,"amount":6078.359913,"timestamp":1721654970114},"postHourTrading":{"tag":"盘后","latestPrice":28.3,"preClose":28.3,"latestTime":"18:04 EDT","volume":21185,"amount":599545.9704,"timestamp":1721426643570},"volumeRatio":0.4441,"impliedVol":0.5135,"impliedVolPercentile":0.1753},"requestUrl":"/m/hq/s/ARWR/wiki","defaultTab":"wiki","newsList":[{"id":"2452915222","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.04%报28.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452915222","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452915222?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:32","pubTimestamp":1721223175,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时32分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅下跌5.04%。截至发稿,该股报28.05美元/股,成交量2.0793万股,换手率0.02%,振幅1.96%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.83%。其相关个股中,Aditxt, Inc.、Longeveron Inc.、Aptevo Therapeutics Inc.涨幅较大,Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃,换手率分别为681.85%、486.06%、106.02%,振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Ginkgo Bioworks Holdings, Inc.、Aditxt, Inc.,振幅分别为18.94%、15.31%、15.00%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213255aefa253b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213255aefa253b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4588","BK4585","BK4139"],"gpt_icon":1},{"id":"2451911833","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.23%报30.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451911833","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451911833?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:11","pubTimestamp":1721142704,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时11分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.23%。截至发稿,该股报30.37美元/股,成交量47.0939万股,换手率0.38%,振幅5.54%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Silo Pharma, Inc.、Virpax Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.涨幅较大,Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2616.56%、1223.73%、355.64%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.,振幅分别为79.41%、61.68%、57.94%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231144aef9f723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231144aef9f723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4007","VRPX","BK4585","BK4588","BK4139"],"gpt_icon":1},{"id":"2449269662","title":"美国研究综述-星座品牌公司、边疆集团控股公司、精神航空公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2449269662","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449269662?lang=zh_cn&edition=full","pubTime":"2024-07-05 20:03","pubTimestamp":1720180997,"startTime":"0","endTime":"0","summary":" 路透7月5日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,其中包括星座品牌公司、边疆集团控股公司和精神航空公司。* 穆迪公司 :摩根士丹利将目标价从374.00美元上调至392.00美元 * S&P Global Inc :摩根士丹利将目标价从500.00美元上调至510.00美元 * 精神航空 :雷蒙德-詹姆斯将其评级从 \"市场表现 \"下调至 \"表现不佳\"。* Taboola.Com Ltd :Needham将其目标价从6美元下调至5美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999018857.SGD","LU1585245621.USD","LU1804176565.USD","BK4500","MCO","BK4504","DM","SPGI","BK4524","FUBO","ULCC","LU0868494617.USD","GIS","LU2264538146.SGD","ALGT","BK4588","LU2089283258.USD","BK4585","BK4212","STZ","SGXZ31699556.SGD","SAVE","LU1989772840.SGD","LU1989764664.SGD","ARWR","LU0354030438.USD","LU0354030511.USD","BK4546","LU2089284900.SGD","LU0158827948.USD","LUV","LU1988902786.USD","LU1989772923.USD","SG9999018865.SGD","BK4507","SG9999014880.SGD","BK4169","LU2023251221.USD","LU1989763005.USD","BK4581","TBLA","LU1989764748.USD","BK4161","BK4077","BK4539","IE00B19Z9505.USD","LU1989773731.SGD","LU1989763690.USD","LU1989763427.SGD","BK4139"],"gpt_icon":0},{"id":"2446000300","title":"BUZZ--美国股票走势-Arrowhead Pharmaceuticals、Nvidia、Alimera Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2446000300","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446000300?lang=zh_cn&edition=full","pubTime":"2024-06-25 01:58","pubTimestamp":1719251898,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月24日 - 周一,蓝筹股道指创下一个月新高,市场普遍反弹,投资者纷纷撤出与人工智能相关的股票,而市场焦点转向本周晚些时候公布的关键通胀数据,以加强对今年降息的押注。美东时间13:42,道琼斯工业平均指数 上涨0.65%,报39,405.62点。标普500指数 下跌0.01%,报5464.16点;纳斯达克综合指数 下跌0.69%,报17566.534点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","LU0310800965.SGD","SDOW","LU0289961442.SGD","LU0642271901.SGD","UDOW","SQ","FDX","IE00BDCRKT87.USD","DJX","ALNY","SON","NNE","BK4575","MAX","COIN","BUZZ","LU0109392836.USD","RIOT","LU1316542783.SGD","NVDA","PSQ","SMCI","MU","EOSE","SQQQ","BK4077","MARA","DDM","NQmain","ALIM","AFRM","MNQmain","IE00BJJMRY28.SGD","DOG","RXO","BK4528","BA","CARR","QLD","RMD","PYPL","SNV",".DJI","DXD","QID","TQQQ","QQQ","BK4529",".IXIC"],"gpt_icon":0},{"id":"2445280006","title":"BUZZ--美国股票走势-布洛克、梅塔、Eos 能源","url":"https://stock-news.laohu8.com/highlight/detail?id=2445280006","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445280006?lang=zh_cn&edition=full","pubTime":"2024-06-24 23:45","pubTimestamp":1719243934,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月24日 - 纳斯达克指数周一下滑,受Nvidia和其他芯片股疲软拖累,同时投资者为本周一项关键的通胀数据做准备,该数据可能进一步影响对降息时机和幅度的押注。美东时间11:32,道琼斯工业平均指数 上涨0.99%,报39,536.89点。标普500指数 上涨0.27%,报5479.62点;纳斯达克综合指数 下跌0.31%,报17635.091点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FDX","CARR","MARA","COIN","META","IE00B1XK9C88.USD","BK4516",".DJI",".SPX","QID","BK4564","DXD","RXO","IE00B19Z3B42.SGD","RMD","SQQQ","SMCI","BK4232","ALNY","DOG","IE00BJTD4N35.SGD","ARWR","LU1571399168.USD","QQQ","EOSE","MU","BK4550","NVDA","MNQmain","RIOT","BK4512","AFRM","UDOW","BA","SNV","SQ","BUZZ",".IXIC","SON","DJX","PSQ","SDOW","BK4112","DDM","IE0004445239.USD","QLD","TQQQ","GB00BDT5M118.USD","LU0648001328.SGD","NQmain","BK4567"],"gpt_icon":0},{"id":"2445076156","title":"BUZZ-肥胖症治疗临床前数据良好,Arrowhead 公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2445076156","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445076156?lang=zh_cn&edition=full","pubTime":"2024-06-24 20:39","pubTimestamp":1719232782,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月24日 - ** Arrowhead制药公司 股价盘前上涨3.5%至26.40美元** 该公司称,临床前数据显示 (link),其基于RNAi的药物ARO-INHBE大大抑制了一种与体重有关的基因 的表达 ** 公司称抑制 INHBE 基因可阻止 体重增加,减少脂肪含量,保持瘦肉含量** RNAi 或 RNA 干扰技术用于抑制导致特定疾病的基因表达** ARWR 计划在 2024 年底申请监管许可,以开始 ARO-INHBE 的临床研究** 截至上次收盘,股价累计下跌 16.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","BK4139","BK4588","BUZZ","BK4585"],"gpt_icon":0},{"id":"2442554560","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.11%报25.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442554560","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442554560?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199129,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.11%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。消息层面,截至21时32分,《H.C. Wainwright维持Arrowhead Pharmaceuticals买入评级,维持目标价90美元》资讯为影响Arrowhead Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213210aef49721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213210aef49721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ARWR","BK4588","BK4139"],"gpt_icon":0},{"id":"2440547009","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440547009","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440547009?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":" 路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻 * Brixmor Property Group Inc :高盛将该公司列入其在美上市公司信用评级名单 * 霍尼韦尔国际公司 :加拿大皇家银行将目标价从222美元下调至218美元 * 西蒙地产集团 :高盛将其股票从美国定罪名单中删除 * Stericycle Inc :加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARWR","BK4539","BK4082","BK4187","BWMN","HHH","SRCL","TGT","HUM","SGC","S","CLSK","LU1621768115.EUR","BK4088","LU2286300806.USD","GPCR","BK4155","LU1621767810.EUR","CMCO","AGIO","HON","SPG","GTLB","BK4154","BA","SG9999014013.SGD","BK4532","SRE","ENPH","LU0823414478.USD","SO","EW","IE00BMG7P587.USD","GMAB","ZS","QCOM","LU1267930227.SGD","BRX","TOL","FWONK","BK4080","MARA","FSLR","EQT","TER","LU1621767737.EUR","IE00BMG7P694.USD","RIOT"],"gpt_icon":0},{"id":"2440470047","title":"美国研究综述-霍尼韦尔国际公司、Stericycle、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2440470047","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440470047?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:29","pubTimestamp":1717486180,"startTime":"0","endTime":"0","summary":" 路透6月4日 - 华尔街证券分析师周二调整了对霍尼韦尔国际公司、Stericycle 和目标公司等几家美国上市公司的评级和目标价。要闻 * Brixmor Property Group Inc :高盛将该公司列入其在美上市公司信用评级名单 * 霍尼韦尔国际公司 :加拿大皇家银行将目标价从222美元下调至218美元 * 西蒙地产集团 :高盛将其股票从美国定罪名单中删除 * Stericycle Inc :加拿大皇家银行将其评级从 \"跑赢大盘 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","MARA","HON","IE00BMG7P587.USD","SPG","BK4080","BK4155","GMAB","SG9999014013.SGD","QCOM","SRCL","LU1267930227.SGD","LU2286300806.USD","LU1621768115.EUR","BRX","LU1621767737.EUR","EQT","BK4088","ZS","BA","TOL","CLSK","BK4532","LU0823414478.USD","TER","LU1621767810.EUR","SGC","BWMN","ARWR","BK4154","AGIO","HUM","SO","ENPH","BK4082","GTLB","BK4187","FWONK","CMCO","BK4539","IE00BMG7P694.USD","S","RIOT","SRE","EW","HHH","FSLR","TGT"],"gpt_icon":0},{"id":"2440499397","title":"BUZZ-遗传性疾病治疗试验成功,艾睿达公司获益匪浅","url":"https://stock-news.laohu8.com/highlight/detail?id=2440499397","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440499397?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:10","pubTimestamp":1717423832,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月3日 - ** 疗法开发商 Arrowhead Pharmaceuticals 股价上涨 7.6% 至 24.69 美元** 该公司称其疗法plozasiran在一项晚期研究中达到了主要目标 (link),并在评估家族性乳糜微粒血症综合征(FCS)患者的所有次要目标(FCS)** 称 plozasiran 可显著降低血液中一种名为甘油三酯的脂肪的中位数。** FCS 是一种罕见的危及生命的疾病,会阻碍人体消化脂肪** 包括本交易日在内,该股今年累计下跌 19.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4588","BK4533","BK4585","BK4140","BK4139","ARW","LU2087621335.USD","LU1839511570.USD","ARWR"],"gpt_icon":0},{"id":"2438306760","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438306760","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438306760?lang=zh_cn&edition=full","pubTime":"2024-05-28 23:02","pubTimestamp":1716908568,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日23时02分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价快速下挫5.12%。截至发稿,该股报23.61美元/股,成交量15.9611万股,换手率0.13%,振幅6.99%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.82%。其相关个股中,Insmed Incorporated、Calliditas Therapeutics Ab、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Exicure, Inc.、Mustang Bio, Inc.、Scorpius Holdings, Inc.较为活跃,换手率分别为56.15%、48.72%、17.49%,振幅较大的相关个股有Exicure, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Mustang Bio, Inc.,振幅分别为76.39%、33.14%、28.59%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528230249aef21db5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528230249aef21db5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ARWR","BK4588"],"gpt_icon":0},{"id":"2436594681","title":"Arrowhead Pharmaceuticals, Inc.2024财年第一财季实现净利润-1.25亿美元,同比减少356.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436594681","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436594681?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:26","pubTimestamp":1715963203,"startTime":"0","endTime":"0","summary":"3月31日,Arrowhead Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第一财季净利润为-1.25亿美元,同比减少356.78%;其中营业收入为0.00美元,每股基本收益为-1.02美元。从资产负债表来看,Arrowhead Pharmaceuticals, Inc.总负债4.60亿美元,其中短期债务5.29百万美元,资产负债比为2.08,流动比率为0.09。机构评级:截至2024年3月31日,当前有14家机构对Arrowhead Pharmaceuticals, Inc.目标价做出预测,其中目标均价为52.38美元,其中最低目标价为27.00美元,最高目标价为90.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800264587750e27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051800264587750e27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR"],"gpt_icon":0},{"id":"2435751699","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 快速拉升5.12%报23.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435751699","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435751699?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:34","pubTimestamp":1715693668,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时34分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.12%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。消息层面,截至21时34分,《大摩:维持Arrowhead Pharma评级,由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。》资讯为影响Arrowhead Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421342987e87cd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421342987e87cd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","ARWR"],"gpt_icon":0},{"id":"2435330840","title":"大摩:维持Arrowhead Pharma(ARWR.US)评级,由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435330840","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435330840?lang=zh_cn&edition=full","pubTime":"2024-05-14 00:45","pubTimestamp":1715618707,"startTime":"0","endTime":"0","summary":"大摩:维持Arrowhead Pharma(ARWR.US)评级,由持股观望调整至持股观望评级, 目标价由36.00美元调整至27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400450887633cf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051400450887633cf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR"],"gpt_icon":0},{"id":"2434525138","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.40%报23.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434525138","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434525138?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:05","pubTimestamp":1715349932,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时05分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.40%。截至发稿,该股报23.39美元/股,成交量15.1445万股,换手率0.12%,振幅7.85%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510220533792707dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240510220533792707dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2434855383","title":"美国研究综述-Cerence、Epam Systems、Progyny","url":"https://stock-news.laohu8.com/highlight/detail?id=2434855383","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434855383?lang=zh_cn&edition=full","pubTime":"2024-05-10 20:39","pubTimestamp":1715344798,"startTime":"0","endTime":"0","summary":" 路透5月10日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价,其中包括 Cerence、Epam Systems 和 Progyny。要闻 * Cerence Inc :富国银行将其评级从 \"增持 \"下调至 \"等权重\"。* Epam Systems Inc :丰业银行将其评级从 \"跑赢大市 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IFF","GAIN","BK4548","MTRN","GRWG","BK4227","BIGC","GFF","MKSI","CE","EPAM","ARWR","PGNY","ARHS","MRCY","APLT","BRT","GO","FDMT","LU0823414478.USD","LU2463526074.USD","LYFT","LU0053671581.USD","CPAY","CRNX","HLIO","BK4533","OBDC","LU1815336091.USD","LU0320765992.SGD","BK4539","ANIK","CMI","CRL","ACAD","FLNC","FOLD","NTLA","BK4109","HBI","MRC","BK4113","YOU","NTRA","MGNX","OXY","IE00B66KJ199.SGD","AVAH","EYE","FWRD"],"gpt_icon":0},{"id":"2434023434","title":"Arrowhead Pharmaceuticals Inc 公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434023434","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434023434?lang=zh_cn&edition=full","pubTime":"2024-05-10 05:02","pubTimestamp":1715288546,"startTime":"0","endTime":"0","summary":" * Arrowhead Pharmaceuticals Inc 公布的截至三月份的季度调整后每股亏损为1.02美元,低于去年同期的每股收益45美分。14 位分析师对该季度的平均预期是每股亏损 16 美分。华尔街预期为每股-95 美分至 3.27 美元。* Arrowhead Pharmaceuticals Inc 的股价本季度下跌了 11.8%,今年迄今为止下跌了 17.6%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Arrowhead Pharmaceuticals Inc 的 12 个月目标价中位数为 55.00 美元。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","ARWR","BK4139","BK4585"],"gpt_icon":0},{"id":"2426909794","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426909794","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426909794?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:46","pubTimestamp":1712756811,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时46分,Arrowhead Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.03%。截至发稿,该股报24.93美元/股,成交量5.083万股,换手率0.04%,振幅1.75%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.37%。其相关个股中,Adial Pharmaceuticals, Inc、Tc Biopharm Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大,Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃,换手率分别为1289.04%、70.50%、26.74%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Calidi Biotherapeutics, Inc.、Silo Pharma, Inc.,振幅分别为61.06%、31.96%、24.26%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021465187e7f4d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021465187e7f4d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","ARWR"],"gpt_icon":0},{"id":"2424462570","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大跌5.21%报26.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424462570","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424462570?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:01","pubTimestamp":1712066483,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日22时01分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价快速下挫5.21%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.38%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。消息层面,截至22时01分,《Form 144 | Arrowhead Pharmaceuticals高管拟出售6,000股股份,价值约16.82万美元》资讯为影响Arrowhead Pharmaceuticals, Inc.的重要信息。该信息摘要如下:根据美国证券交易委员会美东时间4月1日披露的文件,$Arrowhead Pharmaceuticals $高管Hamilton James C拟于4月1日出售6,000股普通股股份,总市值约16.82万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220123861e303d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402220123861e303d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2421045723","title":"Arrowhead Pharmaceuticals, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421045723","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421045723?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:41","pubTimestamp":1711028461,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时41分,Arrowhead Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.04%。Arrowhead Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.71%。Arrowhead Pharmaceuticals, Inc.公司简介:Arrowhead Pharmaceuticals Inc是一家美国生物技术公司。消息层面,截至21时41分,Arrowhead Pharmaceuticals, Inc.股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214101861e019b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321214101861e019b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARWR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arrowheadpharma.com","stockEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":0.2004},{"period":"3month","weight":0.2674},{"period":"6month","weight":-0.1615},{"period":"1year","weight":-0.1872},{"period":"ytd","weight":-0.0752}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arrowhead Pharmaceuticals, Inc.最初于1989年在南达科他州注册成立,后在特拉华州重新注册成立。该公司开发药物,通过沉默疾病的基因来治疗疑难杂症。使用广泛的RNA化学组合和高效的递送模式,该公司的疗法触发RNA干扰机制,以诱导目标基因的快速、深度和持久敲低。该公司已将资源集中于在跨越多个治疗领域的多个动物模型中独家利用其高水平药理活性的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.45,"avgChangeRate":0.005728},{"month":2,"riseRate":0.5,"avgChangeRate":-0.002685},{"month":3,"riseRate":0.55,"avgChangeRate":0.072176},{"month":4,"riseRate":0.45,"avgChangeRate":0.022654},{"month":5,"riseRate":0.35,"avgChangeRate":0.000886},{"month":6,"riseRate":0.6,"avgChangeRate":0.025465},{"month":7,"riseRate":0.6,"avgChangeRate":0.056644},{"month":8,"riseRate":0.421053,"avgChangeRate":0.002555},{"month":9,"riseRate":0.526316,"avgChangeRate":0.050964},{"month":10,"riseRate":0.45,"avgChangeRate":-0.042406},{"month":11,"riseRate":0.5,"avgChangeRate":0.037176},{"month":12,"riseRate":0.45,"avgChangeRate":0.061288}],"exchange":"NASDAQ","name":"Arrowhead Research Corporation","nameEN":"Arrowhead Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arrowhead Research Corporation,ARWR,Arrowhead Research Corporation股票,Arrowhead Research Corporation股票老虎,Arrowhead Research Corporation股票老虎国际,Arrowhead Research Corporation行情,Arrowhead Research Corporation股票行情,Arrowhead Research Corporation股价,Arrowhead Research Corporation股市,Arrowhead Research Corporation股票价格,Arrowhead Research Corporation股票交易,Arrowhead Research Corporation股票购买,Arrowhead Research Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arrowhead Research Corporation(ARWR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arrowhead Research Corporation(ARWR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}